SAS Institute Inc (1999) SAS/STAT user’s guide. Santos-Burgoa C, Matanoski GM, Zeger S, Schwartz L (1992) Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Perez HL, Lahdetie J, Landin H, Kilpelainen I, Koivisto P, Peltonen K, Osterman-Golkar, S (1997) Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Peltonen K, Vaaranrinta R (1995) Sampling and analysis of 1,3-butadiene in air by gas chromatography on a porous-layer open-tubular fused-silica column. Osterman-Golkar S, Peltonen K, Anttinen-Klemetti T, Landin HH, Zorcec V, Sorsa M (1996) Haemoglobin adducts as biomarkers of occupational exposure to 1,3- butadiene. In: Occupational Safety & Health Administration, US Department of Labour, Introduction to 29 CRF, parts 1910, 19 Occupational Safety and Health Administration (1997) Occupational exposure to 1,3-butadiene. Morrow NL (1990) The industrial production and use of 1,3-butadiene. Matanoski GM, Santos-Burgoa C, Schwartz L (1990) Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943–1982). Lynch J (2001) BD monomer and elastomer production processes. Kosaric N, Duvnjak Z, Farkas A (eds) (1987) Ullman’s encyclopedia of industrial chemistry. Kirchner E (1996) Growth of top 50 chemicals slowed in 1995 from very high 1994 rate. Kauppinen T, Toikkanen J, Pedersen D, Young R, Ahrens W, Boffetta P Hansen J, Kromhout H, Maqueda Blasco J, Mirabell, D, de la Orden-Rivera V, Pannett B, Plato N, Savela A, Vincent R, Kogevinas, M (2000) Occupational exposure to carcinogens in the European Union. Ilmatieteen laitos (2003) (Meteorological office) (In Finnish). IARC (1999) IARC monographs on the evaluation of carcinogenic risk to humans 71:109–225 Hayes RB, Zhang L, Swenberg JA, Yin S, Xi L, Wiencke J, Bechtold WE, Yao M, Rothman N, Haas R, O’Neill JP, Wiemels J, Dosemeci M, Li G, Smith MT (2001) Markers for carcinogenicity among butadiene-polymer workers in China. Hase A, Korpinen S, Riistama K, Vuori M (1998) Suomen Kemianteollisuus. International Agency for Research on Cancer, Lyon, pp 3–13įraser I (2001) Butadiene-progress under the European Union Existing Substances Regulation. In: Sorsa M, Peltonen K, Vainio H, Hemminki K (eds) Butadiene and styrene: assessment of health hazards. įajen JM, Lunsford RA, Roberts DR (1993) Industrial exposure to 1,3-butadiene in monomer, polymer and end-user industries. TRGS 102:37–41ĮHP Online (2002) Report on carcinogens, tenth edition US Department of Health and Human Services, Public Health Service, National Toxicology Program, December 2002. Merck, New York, pp 248–249ĭeutscher Ausschuss für Gefahrstoffe (1992) TRK-Wert für 1.3-Butadiene. Toxicol Appl Pharmacol 127:44–49īudavari S (ed) (1996) In: Merck Index, 12th edn. J Chromatogr B 730:257–264īechtold WE, Strunk MR, Chang IY, Ward JB, Jr., Henderson RF (1994) Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans. J Appl Toxicol 3:272–290Īnttinen-Klemetti T, Vaaranrinta R, Peltonen K (1999) Gas chromatographic determination of 3-butene-1,2-diol in urine samples after 1,3-butadiene exposure. WHO, Copenhagen, pp 199–204Īmoore JE, Hautala E (1983) Odor as an aid to chemical safety: odor thresholds compared with threshold limit values and volatilities for 214 industrial chemicals in air and water dilution. In: WHO Occupational Health in the Chemical Industry. Ahlberg R, Sorsa M, Pfaffli P, Maki-Paakkanen J, Viinanen R (1992) Genotoxicity and exposure assessment in the manufacture of 1,3-butadiene.
0 Comments
Leave a Reply. |